Ignite Creation Date:
2024-05-05 @ 4:58 PM
Last Modification Date:
2024-10-26 @ 9:26 AM
Study NCT ID:
NCT00356304
Status:
COMPLETED
Last Update Posted:
2014-05-08
First Post:
2006-07-21
Brief Title:
Motivational Interviewing to Improve Medication Adherence Among Hispanic Adults With Depression
Sponsor:
University of Medicine and Dentistry of New Jersey
Organization:
Rutgers The State University of New Jersey
Study Overview
Official Title:
Antidepressant Adherence Among Hispanics A Motivational Interviewing Approach
Status:
COMPLETED
Status Verified Date:
2014-04
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This study will determine the effectiveness of motivational interviewing in improving antidepressant medication adherence among Hispanics
Detailed Description:
Depression is a serious mental illness characterized by symptoms that can interfere with a persons ability to work study eat sleep and enjoy activities that were once pleasurable Studies have shown that people of Hispanic descent tend to underutilize mental health care services Additionally Hispanics have demonstrated lower compliance and completion rates for antidepressant treatment This may be due to low socioeconomic status lack of family financial support and inadequate communication with mental health care providers Motivational interviewing is a goal-oriented type of therapy that focuses on eliciting behavior change by identifying and mobilizing a persons values This study will determine the effectiveness of culturally sensitive motivational interviewing in improving antidepressant medication adherence in Hispanics
Participants in this 6-month open-label study will be randomly assigned to receive either motivational interviewing in addition to their antidepressant therapy or treatment as usual All participants will first attend a 45-minute screening visit which will include questionnaires and an interview about psychiatric symptoms medication attitudes and medication adherence behavior Participants will also receive an electronic medication container that will record how consistently medication is taken Participants assigned to motivational interviewing will then attend two 1-hour sessions of motivational interviewing over 2 consecutive weeks followed by a third session 8 weeks later The group assigned to treatment as usual will not partake in motivational interviewing but will continue to receive their normal care All participants will return to the study site for follow-up assessments which will include measures of antidepressant adherence at Months 2 and 5
Participants in this 6-month open-label study will be randomly assigned to receive either motivational interviewing in addition to their antidepressant therapy or treatment as usual All participants will first attend a 45-minute screening visit which will include questionnaires and an interview about psychiatric symptoms medication attitudes and medication adherence behavior Participants will also receive an electronic medication container that will record how consistently medication is taken Participants assigned to motivational interviewing will then attend two 1-hour sessions of motivational interviewing over 2 consecutive weeks followed by a third session 8 weeks later The group assigned to treatment as usual will not partake in motivational interviewing but will continue to receive their normal care All participants will return to the study site for follow-up assessments which will include measures of antidepressant adherence at Months 2 and 5
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| DSIR 8K-RT | US NIH GrantContract | None | httpsreporternihgovquickSearchK23MH074860 |
| K23MH074860 | NIH | None | None |